The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Catherine Patte

Institut Gustave Roussy

Pediatric Department




Name/email consistency: high



  • Institut Gustave Roussy, Pediatric Department, Villejuif, France. 2002 - 2007
  • Pediatrics Department, Institut Gustave Roussy, Rue Camille Desmoulins, 94805 Villejuif Cedex, France. 2001 - 2002


  1. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Patte, C., Auperin, A., Gerrard, M., Michon, J., Pinkerton, R., Sposto, R., Weston, C., Raphael, M., Perkins, S.L., McCarthy, K., Cairo, M.S. Blood (2007) [Pubmed]
  2. Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology. Patte, C., Laplanche, A., Bertozzi, A.I., Baruchel, A., Frappaz, D., Schmitt, C., Mechinaud, F., Nelken, B., Boutard, P., Michon, J. J. Clin. Oncol. (2002) [Pubmed]
  3. Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol. Patte, C., Sakiroglu, C., Ansoborlo, S., Baruchel, A., Plouvier, E., Pacquement, H., Babin-Boilletot, A. Ann. Oncol. (2002) [Pubmed]
  4. Treatment of mature B-ALL and high grade B-NHL in children. Patte, C. Best. Pract. Res. Clin. Haematol (2002) [Pubmed]
  5. The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Patte, C., Auperin, A., Michon, J., Behrendt, H., Leverger, G., Frappaz, D., Lutz, P., Coze, C., Perel, Y., Raphaël, M., Terrier-Lacombe, M.J. Blood (2001) [Pubmed]
WikiGenes - Universities